In a recent transaction on July 22, Michael Feinsod, the CEO of Bespoke Extracts, Inc. (OTC:BSPK), a company specializing in pharmaceutical preparations, has increased his stake in the company. The transaction involved the purchase of 3,000 shares of common stock at a price of $0.07 per share, amounting to a total investment of $210.
This purchase reflects a continued commitment by the CEO to the company, as it adds to his already substantial holdings. Following the transaction, Feinsod's total ownership in Bespoke Extracts stands at 2,148,112 shares. It is worth noting that of these shares, 1,133,000 are held directly by Mr. Feinsod, and 1,015,112 shares are managed by Infinity Management, LLC, where he is the managing member.
Investors often keep a close watch on insider transactions such as these, as they can provide insights into the executives' confidence in the company's future prospects. The transaction was filed with the Securities and Exchange Commission and is publicly available for review.
Bespoke Extracts, Inc., headquartered in Denver, Colorado, has been known by various names in the past, including DiMi Telematics International, Inc. and First Quantum (NASDAQ:QMCO) Ventures Inc. The company has seen its focus shift over the years, but under its current name, it is engaged in the development and commercialization of pharmaceutical products.
InvestingPro Insights
Bespoke Extracts, Inc. (OTC:BSPK) has recently been the subject of increased attention due to the CEO's investment in the company's stock. With a market capitalization of just $0.75 million, Bespoke Extracts is a small player in the pharmaceutical preparations industry. The company's financial metrics reveal a challenging landscape: a negative P/E ratio of -0.64 and a significant revenue growth of 970.77% in the last twelve months as of Q1 2024. These figures underscore the volatile nature of the company's stock, which aligns with one of the InvestingPro Tips highlighting high price volatility in its trading patterns.
Further scrutiny through InvestingPro Tips suggests that Bespoke Extracts has not been profitable over the last twelve months, and it has been grappling with short-term obligations that exceed its liquid assets. Additionally, the company does not pay dividends to shareholders, which may be a consideration for income-focused investors. On the positive side, the company has experienced a notable return of 8.88% over the last week, although its longer-term performance has been less encouraging with a one-year price total return of -45.27%.
For investors intrigued by the CEO's recent share purchase and considering a deeper dive into Bespoke Extracts, there are additional InvestingPro Tips available to help make an informed decision. In fact, there are five more tips listed on InvestingPro that could provide further insights into the company's financial health and stock performance. To access these valuable insights and more, investors can visit https://www.investing.com/pro/BSPK and use the coupon code PRONEWS24 to get up to 10% off a yearly Pro and a yearly or biyearly Pro+ subscription.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.